Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience

Br J Haematol. 2021 Jan;192(2):e54-e57. doi: 10.1111/bjh.17217. Epub 2020 Nov 20.

Authors

Quentin A Hill¹, Matthew Horan², Andrew Charlton², Tom Bullock³, Edwin Massey³, Anita Hill¹, Shubha Allard⁴, Simon J Stanworth^{5

6

7}

Affiliations

¹ Leeds Teaching Hospitals, Leeds, UK.
² NHS Blood and Transplant, Newcastle upon Tyne, UK.
³ NHS Blood and Transplant, Bristol, UK.
⁴ NHS Blood and Transplant, London, UK.
⁵ NHS Blood and Transplant, Oxford, UK.
⁶ Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁷ Radcliffe Department of Medicine and Oxford BRC Haematology Theme, University of Oxford, Oxford, UK.

PMID: 33216965
DOI: 10.1111/bjh.17217

No abstract available

Keywords: autoimmune haemolytic anaemia; health-related quality of life; patient-reported outcomes; registry.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anemia, Hemolytic, Autoimmune / epidemiology
Anemia, Hemolytic, Autoimmune / therapy*
Disease Management
Evidence-Based Medicine
Humans
Prevalence
United Kingdom / epidemiology